Search research articles
Contact Us
Filters
Showing results (21-30 of 234) with videos related to
Page
of 24
Sort By:
Expert Opinion on Therapeutic Patents
|
January 28, 2016
Novel 20(S)-sulfonylamidine derivatives of camptothecin and the use thereof as a potent antitumor agent: a patent evaluation of WO2015048365 (A1)
Giovanni Luca Beretta, Nadia Zaffaroni, Greta Varchi
Current Pharmaceutical Design
|
September 3, 2016
Emerging Role of G-quadruplex DNA as Target in Anticancer Therapy
Graziella Cimino-Reale, Nadia Zaffaroni, Marco Folini
Journal of the National Cancer Institute. Monographs
|
November 2, 2011
Strategies to translate preclinical information to breast cancer patient benefit
Maria Grazia Daidone, Nadia Zaffaroni, Vera Cappelletti
Cancers
|
June 2, 2021
MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer
Valentina Doldi, Rihan El Bezawy, Nadia Zaffaroni
Journal of Cellular and Molecular Medicine
|
June 21, 2005
Survivin as a target for new anticancer interventions
Nadia Zaffaroni, Marzia Pennati, Maria Grazia Daidone
Expert Opinion on Therapeutic Targets
|
January 7, 2011
MicroRNAs as new therapeutic targets and tools in cancer
Paolo Gandellini, Valentina Profumo, Marco Folini, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 17, 2014
Targeting microRNAs to withstand cancer metastasis
Valentina Profumo, Valentina Doldi, Paolo Gandellini, et al.
Current Pharmaceutical Design
|
November 28, 2012
Drug combinations with proteasome inhibitors in antitumor therapy
Laura Gatti, Valentina Zuco, Nadia Zaffaroni, et al.
Trends in Molecular Medicine
|
August 26, 2014
miRNAs in tumor radiation response: bystanders or participants?
Paolo Gandellini, Tiziana Rancati, Riccardo Valdagni, et al.
International Journal of Molecular Sciences
|
June 2, 2021
On the Road to Fight Cancer: The Potential of G-quadruplex Ligands as Novel Therapeutic Agents
Irene Alessandrini, Marta Recagni, Nadia Zaffaroni, et al.
Page
of 24
Search research articles
Search
Showing results (21-30 of 234) with videos related to
Sort By:
Page
of 24
Expert Opinion on Therapeutic Patents
|
January 28, 2016
Novel 20(S)-sulfonylamidine derivatives of camptothecin and the use thereof as a potent antitumor agent: a patent evaluation of WO2015048365 (A1)
Giovanni Luca Beretta, Nadia Zaffaroni, Greta Varchi
Current Pharmaceutical Design
|
September 3, 2016
Emerging Role of G-quadruplex DNA as Target in Anticancer Therapy
Graziella Cimino-Reale, Nadia Zaffaroni, Marco Folini
Journal of the National Cancer Institute. Monographs
|
November 2, 2011
Strategies to translate preclinical information to breast cancer patient benefit
Maria Grazia Daidone, Nadia Zaffaroni, Vera Cappelletti
Cancers
|
June 2, 2021
MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer
Valentina Doldi, Rihan El Bezawy, Nadia Zaffaroni
Journal of Cellular and Molecular Medicine
|
June 21, 2005
Survivin as a target for new anticancer interventions
Nadia Zaffaroni, Marzia Pennati, Maria Grazia Daidone
Expert Opinion on Therapeutic Targets
|
January 7, 2011
MicroRNAs as new therapeutic targets and tools in cancer
Paolo Gandellini, Valentina Profumo, Marco Folini, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 17, 2014
Targeting microRNAs to withstand cancer metastasis
Valentina Profumo, Valentina Doldi, Paolo Gandellini, et al.
Current Pharmaceutical Design
|
November 28, 2012
Drug combinations with proteasome inhibitors in antitumor therapy
Laura Gatti, Valentina Zuco, Nadia Zaffaroni, et al.
Trends in Molecular Medicine
|
August 26, 2014
miRNAs in tumor radiation response: bystanders or participants?
Paolo Gandellini, Tiziana Rancati, Riccardo Valdagni, et al.
International Journal of Molecular Sciences
|
June 2, 2021
On the Road to Fight Cancer: The Potential of G-quadruplex Ligands as Novel Therapeutic Agents
Irene Alessandrini, Marta Recagni, Nadia Zaffaroni, et al.
Page
of 24